FSD Pharma - HUGE Net earnings per share growth forecast for next year

Corporate company logo of FSD Pharma (HUGE)

FSD Pharma Inc. (HUGE) brings together leading neurologists developing innovative brain medications. The projected EPS growth rate confirms the asset's momentum, where 0.00 indicates the current level. The company competes for capital with small pre-commercial biotech startups. The R&D model assumes a cash burn until formulas are patented, which will ensure high margins without capital expenditures.

FSD Pharma (HUGE): Net earnings per share growth forecast for next year from 07/04/2022 to 08/15/2024

Summary analytical data breakdowns for fsdpharma.com (HUGE)

- price and consensus price forecast:
Price Chart FSD Pharma Inc.|HUGE - Fair Value Consensus
- issuer market value details:
Market Value FSD Pharma|HUGE - Total Enterprise Value
- company book value details:
Net Assets per Single Share FSD Pharma|HUGE - Company Book Value|Market Value to Book Value Ratio fsdpharma.com|HUGE - Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital FSD Pharma Inc.|HUGE - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio FSD Pharma|HUGE - Company Cumulative Debt|Debts to Book Capitalization FSD Pharma|HUGE - Long-Term Liabilities|Company Short-Term Debt FSD Pharma|Quick Ratio fsdpharma.com
- net income and valuation ratios data:
HUGE - Company Profit|Future Profit FSD Pharma Inc.|HUGE - Company Value to Net Income|Future Price to Earnings FSD Pharma Inc.|HUGE - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple FSD Pharma|HUGE - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) FSD Pharma|HUGE - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months fsdpharma.com|HUGE - Earnings per share increase in current year|Net earnings per share growth forecast for next year FSD Pharma Inc.
- company sales and revenue statistics:
HUGE - Company Sales|Projected Sales Volume FSD Pharma|HUGE - P/S Multiple|Forward Price-to-Revenue Multiple FSD Pharma
Fundamental company analysis:FSD Pharma Inc., HUGE
Finished products of FSD Pharma, Inc.

This indicator measures the consensus forecast of professional analysts regarding the change in earnings per share (EPS) for the coming year, reflecting market expectations for future business profitability. The current value of 0.00 and the trend of EPS growth forecasts are critical for FSD Pharma Inc. (HUGE), as the potential commercialization of patented brain treatment drugs promises a sharp surge in margins.

Who FSD Pharma Inc. competes with

Net earnings per share growth forecast for next year Jazz Pharma|CYTK: Expected earnings per share trend next year|Net earnings per share growth forecast for next year PTC Therapeutics, Inc. (PTCT)|SRRK - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Centessa CNTA|Dyne Therapeutics Inc - Net earnings per share growth forecast for next year|EWTX - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Rapport Corp|ALMS: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year zevra.com ZVRA|Expected earnings per share growth for next year CTNM|Expected net earnings per share growth next year Larimar Therapeutics Inc LRMR|Earnings growth forecast for next year CAPR|TRDA: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Channel Therapeutics PTHS|Consensus forecast of earnings per share growth for next year MediciNova Inc. (MNOV)|Serina Therapeutics - Earnings growth forecast for next year|BTAI (BioXcel Therapeutics Inc) - Projected earnings per share growth rate for next year|PMN (promisneurosciences.com) - Expected earnings per share growth for next year|Apimeds Pharmaceuticals US - Expected earnings per share trend next year|Net earnings per share growth forecast for next year AEON Biopharma Inc.|NLS Pharma - Net earnings per share change forecast for next year|Earnings growth forecast for next year BNOX|RETA (Reata Pharmaceuticals Inc) - Expected earnings per share trend next year